The SARS-CoV-2 main protease as drug target

por Ullrich, Sven, Nitsche, Christoph
Publicado 2020

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

por Ullrich, Sven, Nitsche, Christoph
Publicado 2022

Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir

por Ullrich, Sven, Ekanayake, Kasuni B., Otting, Gottfried, Nitsche, Christoph
Publicado 2022

Biocompatible and Selective Generation of Bicyclic Peptides

por Ullrich, Sven, George, Josemon, Coram, Alexandra E., Morewood, Richard, Nitsche, Christoph
Publicado 2022

Site-selective generation of lanthanoid binding sites on proteins using 4-fluoro-2,6-dicyanopyridine

por Mekkattu Tharayil, Sreelakshmi, Mahawaththa, Mithun C., Feintuch, Akiva, Maleckis, Ansis, Ullrich, Sven, Morewood, Richard, Maxwell, Michael J., Huber, Thomas, Nitsche, Christoph, Goldfarb, Daniella, Otting, Gottfried
Publicado 2022

Challenges of short substrate analogues as SARS-CoV-2 main protease inhibitors

por Ullrich, Sven, Sasi, Vishnu M., Mahawaththa, Mithun C., Ekanayake, Kasuni B., Morewood, Richard, George, Josemon, Shuttleworth, Laura, Zhang, Xiaobai, Whitefield, Cassidy, Otting, Gottfried, Jackson, Colin, Nitsche, Christoph
Publicado 2021

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2

por Johansen-Leete, Jason, Ullrich, Sven, Fry, Sarah E., Frkic, Rebecca, Bedding, Max J., Aggarwal, Anupriya, Ashhurst, Anneliese S., Ekanayake, Kasuni B., Mahawaththa, Mithun C., Sasi, Vishnu M., Luedtke, Stephanie, Ford, Daniel J., O'Donoghue, Anthony J., Passioura, Toby, Larance, Mark, Otting, Gottfried, Turville, Stuart, Jackson, Colin J., Nitsche, Christoph, Payne, Richard J.
Publicado 2022